Projects
The pharmaceutical projects listed in this section are those that are announced from time to time around the world
Axplora Expands Italy Operations with €80M Farmabios Investment
Axplora is expanding its Farmabios facility in Gropello Cairoli, Italy, with a new 35 million investment This forms part of a broader strategy to boost production capabilities and support future growth
AstraZeneca invests ₹166 Crore to Expand Global Hub in Bangalore
AstraZeneca, a global biopharmaceutical company focused on scientific innovation, has announced a significant expansion of its Global Hub in Bangalore, India The project, backed by an investment of 166 crore
Delpharm Invests CAD 200M to Upgrade Boucherville Sterile Injectables Facility
Delpharm has entered into a strategic agreement with the Government of Canada to modernize its injectable manufacturing facility in Boucherville This initiative ensures that Delpharm continues its operations in Canada
Chiesi Invests €430 Million in New Facility to Advance Therapeutic Manufacturing
Chiesi Group has announced a significant investment to establish a new manufacturing facility in Nerviano, Milan This initiative forms part of the companys wider industrial strategy aimed at supporting international growth and advancing sustainable healthcare solutions
LOTTE BIOLOGICS Announces $100 Million Expansion of ADC Manufacturing Facility
LOTTE BIOLOGICS has signed a manufacturing agreement with a biotechnology company based in Asia for the production of a clinicalstage antibodydrug conjugate ADC candidate
CordenPharma Invests >€1 billion to Expand its Greenfield Facility
CordenPharma has announced plans to invest more than 1 billion over the next three years to build and expand peptide manufacturing facilities across Europe and the United States
Axplora Invests €50 Million in Mourenx Site Construction
Axplora, a global leader in API small molecule and ADC manufacturing, has announced a 50 million investment in its Mourenx facility in southwest France This development aims to strengthen its role in addressing cardiovascular and metabolic diseases
Orano Med Invests €250 Million in New Facility for Lead-212 Radioligand Therapy Precursors
Orano Med, part of the Orano Group and a leader in the development of targeted alpha therapies for cancer treatment, has marked the groundbreaking of its Advanced Thorium Extraction Facility ATEF in France
Novo Nordisk Commits 8.5 Billion to Build New Production Facility in Denmark
Novo Nordisk has revealed plans to invest 85 billion Danish kroner in the construction of a new production facility in Denmark This marks the first time in this century that the company has launched a new production site in Denmark
Ardena Invests €20 million for the Expansion of New Nanomedicine Facility in Netherlands
Ardena has invested 20 million in expanding its nanomedicine manufacturing facility in the Netherlands, achieving full Good Manufacturing Practice GMP certification
